Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Frame

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Seminars in Hematology|August 18, 2005
The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiativesJames N Frame
Southern Medical Journal|February 1, 1993
Rhodococcus equi causing bacteremia in an adult with acute leukemiaG G Sladek, J N Frame
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Gastrointestinal visceral motor complications of dermatomal herpes zoster: report of two cases and reviewD R Tribble, P Church, J N Frame
Archives of Internal Medicine|February 1, 1987
Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destructionW E Samlowski, R N Frame, G L Logue
Blood|January 1, 1988
Vitronectin (S protein) augments the functional activity of monocyte receptors for IgG and complement C3bC J Parker, R N Frame, M R Elstad
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Archives of Dermatology|March 1, 1992
Waldenström macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibodyM W Cobb, N Domloge-Hultsch, J N Frame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemiaB D Cheson, J N Frame, D Vena, et al.
Critical Care Medicine|November 1, 1987
Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysisR N Frame, M C Johnson, M S Eichenhorn, et al.
American Journal of Therapeutics|November 17, 2010
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT StudySteven W Boyce, Dennis F Bandyk, John R Bartholomew, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Seminars in Hematology|August 18, 2005
The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiativesJames N Frame
Southern Medical Journal|February 1, 1993
Rhodococcus equi causing bacteremia in an adult with acute leukemiaG G Sladek, J N Frame
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Gastrointestinal visceral motor complications of dermatomal herpes zoster: report of two cases and reviewD R Tribble, P Church, J N Frame
Archives of Internal Medicine|February 1, 1987
Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destructionW E Samlowski, R N Frame, G L Logue
Blood|January 1, 1988
Vitronectin (S protein) augments the functional activity of monocyte receptors for IgG and complement C3bC J Parker, R N Frame, M R Elstad
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Archives of Dermatology|March 1, 1992
Waldenström macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibodyM W Cobb, N Domloge-Hultsch, J N Frame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemiaB D Cheson, J N Frame, D Vena, et al.
Critical Care Medicine|November 1, 1987
Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysisR N Frame, M C Johnson, M S Eichenhorn, et al.
American Journal of Therapeutics|November 17, 2010
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT StudySteven W Boyce, Dennis F Bandyk, John R Bartholomew, et al.
Pageof 4